SHARE THIS PAGE
CONNECT WITH US
Dr. Chapman approved the OREF-JBJS Journal Club, teamed with HighWire Press for the electronic version of JBJS, and created a CD-ROM version of JBJS. The historic member benefit contract between the AAOS and JBJS was agreed to in 2001.
Dr. Chapman oversaw additional high-level business developments. The Board clarified that JBJS would retain full copyright on all published content, and that it would not grant that copyright to others. Prior to this, exceptions for certain institutions were allowed.
Also, the Trustees agreed that the cover of The Journal of Bone and Joint Surgery would reflect its origins from the American Orthopaedic Association.
Dr. Greene appointed and promoted James Heckman as Editor-in-Chief and Mady Tissenbaum as the General Manager of JBJS, Inc. On December 31, 2002, the Board of Trustees froze the Defined Benefit Plan.
Also under Dr. Greene’s guidance, the agreement to make JBJS a member benefit of the AAOS was officially implemented. After a long-standing relationship, the separation of the American and British versions of The Journal of Bone and Joint Surgery began.
During his tenure, Dr. Greene reaffirmed the ongoing mission of JBJS for excellence in scientific publishing and encouraged the discussion of other alternative educational opportunities.
Dr. Morrey approved Surgical Techniques as a supplement to The Journal of Bone and Joint Surgery.
Dr. Urbaniak determined that JBJS should create a business plan for a commercially viable, online, electronic strategy. The member benefit agreement between the AAOS and JBJS was also revised and extended through 2011.
Dr. DeLee approved free subscriptions for all PGY2 through PGY5 residents and expanded the Journal Club program with the OREF for 2007 and 2008.
Dr. DeLee also initiated succession planning for the Editor role for 2009. The Board of Trustees had previously decided to pursue a position that combined the Editor role with a new CEO role.
Dr. Herndon created the International Development Committee to expand the global JBJS brand, extended the Joint Publishing Agreement with The British Editorial Society, and extended the AAOS/JBJS Member Benefit Agreement.
Under Dr. Herndon’s guidance, the strategic decision was made to change the traditional business model of JBJS—led by an Editor-in-Chief who also served as CEO—to one where the business functions (CEO & CFO) were separated from the editorial functions (Editor-in-Chief). Kent Anderson was hired as the first CEO/Publisher of JBJS.
To facilitate this change, a new Board committee— the Editorial Advisory Committee—was appointed to maintain open communications between the Editor-in-Chief and the Board of Trustees. Dr. Herndon improved Board communications with monthly conference calls and advanced Board education with strategic discussions led by experts at each annual meeting.
Dr. Hanley approved an expansion of journal titles, with the introduction of JBJS Case Connector, JBJS Essential Surgical Techniques, and JBJS Reviews. With Dr. Mark Miller, a joint venture was approved to develop the JBJS Virtual Recertification Course.
Additionally, Dr. Hanley oversaw the new Enterprise growth strategy led by Kent Anderson, CEO. The Enterprise approach would allow JBJS, Inc. to grow and diversify to meet short-term challenges and long-term stability
Under Dr. Hanley’s leadership of the Enterprise approach, the JBJS name was changed to Striatus Orthopaedic Communications, Inc. The relationships with the AAOS and AOA were redefined, establishing JBJS as a totally independent, non-profit organization. The long-standing business relationship between JBJS and its British counterparts was terminated, resulting in the British journal being renamed The Bone and Joint Journal. Also, JBJS moved its publishing platform from Highwire to Silverchair.
Under Dr. Gelberman’s leadership, JBJS entered its first significant publishing agreement with Wolters Kluwer Health, effective beginning 2016. Dr. Gelberman also authorized the asset acquisition of the Journal of Orthopaedics for Physician Assistants, now JBJS JOPA.
Dr. Gelberman also helped reorganize editorial roles at JBJS. He replaced Kent Anderson as CEO/Publisher and then split the responsibilities of the role. Mady Tissenbaum was promoted to Publisher, and Paul Sandford as CEO of JBJS, Inc., in August 2014.
Additionally, JBJS began the use of SocialCite for citation processing. Editorial assets further evolved as the SocialCite project was terminated in December 2014. JBJS preSCORE assets were also sold, and the organization changed its brand back to JBJS, Inc. from Striatus Orthopaedic Communications, Inc. Moving forward, JBJS would focus on the orthopaedic market prospectively.
Dr. Beaty expanded the JBJS product offering by launching JBJS Open Access in partnership with Wolters Kluwer and by building JBJS Clinical Classroom in partnership with NEJM Group and Area 9 Learning.
Dr. Beaty convened the Millennial Advisory Group to consult on the new JBJS website, jbjs.org. JBJS journals were moved from the Highwire platform to jbjs.org and the electronic journals platform of Wolters Kluwer. Under Dr. Beaty’s leadership, the Board of Trustees managed the transition following the termination of the AAOS/JBJS Member Benefit Agreement by the AAOS, which had been in place since 2002.
Further, JBJS sold its building in Needham, MA, at the height of the commercial real estate market, and then leased it back.
Dr. Weiland helped JBJS expand its education portfolio by acquiring The Miller Review Courses from Dr. Mark Miller and by launching the new AOA Critical Issues in Education Channel in JBJS Open Access.
The AOA Critical Issues in Education Channel was launched as part of an expansion of the agreement between JBJS and the American Orthopaedic Association (AOA). Additionally, The Journal of Bone and Joint Surgery and all other journals became a member benefit of the AOA, which allows for all domestic residents to receive JBJS for free via the CORD group.
During Dr. Weiland’s tenure, the Board of Trustees also terminated JBJS’s frozen pension plan and acquired ownership stake in Orthoevidence™, a global online source for high quality and timely orthopaedic‐only evidence‐based summaries that are pre‐appraised by orthopaedic medical experts.
During Dr. Kasser’s term as the Chair of JBJS, he successfully navigated the organization through the Covid-19 Pandemic. This entailed addressing the needs of JBJS stakeholders with regards to new remote methods of conducting business, most significantly transitioning the Miller Review Course to a hybrid learning experience.
Dr. Kasser was instrumental in leading new strategic planning efforts in the organization to address the continued evolution of digital products and technologies that customers will be utilizing to find and engage with orthopaedic research in the future.
Joshua J. Jacobs, MD is the current Chairman of the Board of Trustees for JBJS. An orthopaedic surgeon specializing in total joint replacement, Dr. Jacobs is currently Professor and Chair of the Department of Orthopaedic Surgery and Vice Dean for Research at Rush Medical College in Chicago.
Dr. Jacobs’ extensive leadership resume includes prior service as President of the American Academy of Orthopaedic Surgeons, President of the Orthopaedic Research Society, and President of the Hip Society.
He is a world-renowned researcher investigating materials and techniques for joint replacement who has authored more than 280 peer-reviewed articles, 5 books, and more than 45 book chapters.
Sign up to receive your free JBJS 2020 Special Issue—a compilation of the most-read articles. You get twelve articles across six JBJS publications in this special issue.
